Seer (SEER) Change in Acquisitions & Divestments (2020 - 2026)
Seer (SEER) recorded quarterly Change in Acquisitions & Divestments of $68.3 million in Q1 2026, up 67.98% quarter-over-quarter from $40.6 million in Q4 2025, and down 22.1% on a YoY basis from $87.6 million in Q1 2025.
Seer (SEER) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Seer's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $68.3 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 22.1% year-over-year to $68.3 million; the TTM figure through Mar 2026 stood at $218.4 million (down 26.01% YoY), while the FY2025 annual figure was $237.8 million, down 30.47% from the prior year.
- Change in Acquisitions & Divestments was $68.3 million for Q1 2026 at Seer, up from $40.6 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $442.3 million in Q4 2023 to a low of -$302.6 million in Q3 2023.
- Historically, Change in Acquisitions & Divestments has averaged $96.2 million across 5 years, with a median of $68.5 million in 2024.
- Biggest YoY gain for Change in Acquisitions & Divestments was 4395.18% in 2024; the steepest drop was 84.47% in 2024.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $253.6 million in 2022, then soared by 74.39% to $442.3 million in 2023, then tumbled by 84.47% to $68.7 million in 2024, then tumbled by 40.84% to $40.6 million in 2025, then soared by 67.98% to $68.3 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $68.3 million (Q1 2026), $40.6 million (Q4 2025), and $64.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.26 Mn |
| Mar 31, 2026 | 68.26 Mn |
| Dec 31, 2025 | 40.63 Mn |
| Dec 31, 2025 | 40.63 Mn |
| Sep 30, 2025 | 64.22 Mn |
| Sep 30, 2025 | 64.22 Mn |
| Jun 30, 2025 | 45.34 Mn |
| Jun 30, 2025 | 45.34 Mn |
| Mar 31, 2025 | 87.63 Mn |
| Mar 31, 2025 | 87.63 Mn |
| Dec 31, 2024 | 68.68 Mn |
| Dec 31, 2024 | 68.68 Mn |
| Sep 30, 2024 | 79.32 Mn |
| Sep 30, 2024 | 79.32 Mn |
| Jun 30, 2024 | 59.62 Mn |
| Jun 30, 2024 | 59.62 Mn |
| Mar 31, 2024 | 134.41 Mn |
| Mar 31, 2024 | 134.41 Mn |
| Dec 31, 2023 | 442.33 Mn |
| Dec 31, 2023 | 442.33 Mn |